News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1901 results

LSPN Connect: The battle for COVID-19 vaccines

International22-06-2021Alex Baldwin

With the COVID-19 vaccines developed, we are now faced with the monumental task of distributing hundreds of millions of vaccines across the globe.

SCOTUS won’t resuscitate Amarin’s Vascepa patents

US22-06-2021Muireann Bolger

Amarin has failed to persuade the US Supreme Court to consider reviving six patents on the heart medicine Vascepa, allowing generic drugmakers Hikma Pharmaceuticals and Dr. Reddy’s Laboratories to roll out copycat products.

Bio-Rad asks for review of DNA patent ruling

US17-06-2021Alex Baldwin

Bio-Rad has asked the US Court of Appeals for the Federal Circuit to review its prior decisions that affirmed Bio-Rad had infringed three 10X Genomics patents.

UC Berkeley gets $54k for T-cell patent NFT

US17-06-2021Alex Baldwin

The University of California Berkeley has sold a non-fungible token based on patent disclosures for Nobel Prize-winning cancer immunotherapies research at an online auction, netting approximately $54,360 from the sale.

No payday for GSK over stolen trade secrets

US17-06-2021Rory O'Neill

Two former GlaxoSmithKline researchers do not have to pay restitution for stealing the drugmaker’s trade secrets, a Pennsylvania court has ruled.

Allergan’s Forest to face jury in antitrust suit over Alzheimer drug

US15-06-2021Muireann Bolger

Allergan subsidiary Forest Laboratories will have to argue its case before a jury over claims that it used pay-for-delay deals to keep generic copies of blockbuster Alzheimer drug, Namenda, from the marketplace.

France backs COVID-19 vaccine IP waiver

Canada, France, Germany, UK, US14-06-2021Alex Baldwin

French President Emmanuel Macron has committed to backing the proposal to waive IP rights for COVID-19 vaccines ahead of the G7 Summit taking place in England this weekend.

Oakwood convinces third circuit to reopen TS suit

US10-06-2021Alex Baldwin

Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.

Endo, Impax face class-action over antitrust claims

US07-06-2021Muireann Bolger

Endo International and Amneal Pharmaceuticals’ subsidiary, Impax Laboratories, have failed to prevent antitrust claims over a patent settlement from going to trial.

Clarus succeeds in invalidating four Lipocine testosterone patents

US03-06-2021Alex Baldwin

Clarus Therapeutics has convinced a US court to invalidate four Lipocine testosterone booster patents it was accused of infringing.

Showing 1 to 10 of 1901 results

LSIPR